{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:42:36Z","timestamp":1781725356420,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Basic Science Research Program of the National Research Foundation of Korea","award":["2015R1A2A2A04004455"],"award-info":[{"award-number":["2015R1A2A2A04004455"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5620-6","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T14:57:57Z","timestamp":1557154677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Sunyoung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoon","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunghyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geehyuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwoo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Hwa","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"issue":"2","key":"5620_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"5620_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3945\/an.116.012211","volume":"7","author":"S McGuire","year":"2016","unstructured":"McGuire S. World Cancer report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO press, 2015. Adv Nutr. 2016;7(2):418\u20139.","journal-title":"Adv Nutr"},{"issue":"2","key":"5620_CR3","first-page":"F55","volume":"1288","author":"H zur Hausen","year":"1996","unstructured":"zur Hausen H. Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta. 1996;1288(2):F55\u201378.","journal-title":"Biochim Biophys Acta"},{"issue":"9801","key":"5620_CR4","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0140-6736(11)61351-2","volume":"378","author":"MH Forouzanfar","year":"2011","unstructured":"Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378(9801):1461\u201384.","journal-title":"Lancet"},{"issue":"2","key":"5620_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"issue":"2","key":"5620_CR6","first-page":"255","volume":"1845","author":"JM Bouyssou","year":"2014","unstructured":"Bouyssou JM, Manier S, Huynh D, Issa S, Roccaro AM, Ghobrial IM. Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta. 2014;1845(2):255\u201365.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"5620_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tins.2008.12.003","volume":"32","author":"SS Hebert","year":"2009","unstructured":"Hebert SS, De Strooper B. Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci. 2009;32(4):199\u2013206.","journal-title":"Trends Neurosci"},{"issue":"4","key":"5620_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259\u201369.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"5620_CR9","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1440-1746.2008.05666.x","volume":"24","author":"J Guo","year":"2009","unstructured":"Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009;24(4):652\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"13","key":"5620_CR10","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1158\/0008-5472.CAN-06-0561","volume":"67","author":"WO Lui","year":"2007","unstructured":"Lui WO, Pourmand N, Patterson BK, Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res. 2007;67(13):6031\u201343.","journal-title":"Cancer Res"},{"issue":"16","key":"5620_CR11","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","volume":"65","author":"MV Iorio","year":"2005","unstructured":"Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65(16):7065\u201370.","journal-title":"Cancer Res"},{"issue":"11","key":"5620_CR12","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-04-0637","volume":"64","author":"J Takamizawa","year":"2004","unstructured":"Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64(11):3753\u20136.","journal-title":"Cancer Res"},{"issue":"12","key":"5620_CR13","first-page":"882","volume":"1","author":"MZ Michael","year":"2003","unstructured":"Michael MZ, SM OC, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 2003;1(12):882\u201391.","journal-title":"Mol Cancer Res"},{"key":"5620_CR14","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.biopha.2017.01.117","volume":"88","author":"Z He","year":"2017","unstructured":"He Z, Xu H, Meng Y, Kuang Y. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer. Biomed Pharmacother. 2017;88:902\u201310.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"5620_CR15","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s13277-015-3844-x","volume":"37","author":"H He","year":"2016","unstructured":"He H, Tian W, Chen H, Jiang K. MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer. Tumour Biol. 2016;37(2):1599\u2013607.","journal-title":"Tumour Biol"},{"issue":"5","key":"5620_CR16","doi-asserted-by":"publisher","first-page":"E230","DOI":"10.1002\/ijc.29160","volume":"136","author":"H Xie","year":"2015","unstructured":"Xie H, Lee L, Scicluna P, Kavak E, Larsson C, Sandberg R, Lui WO. Novel functions and targets of miR-944 in human cervical cancer cells. Int J Cancer. 2015;136(5):E230\u201341.","journal-title":"Int J Cancer"},{"issue":"11","key":"5620_CR17","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.prp.2017.09.011","volume":"213","author":"T Powrozek","year":"2017","unstructured":"Powrozek T, Kuznar-Kaminska B, Dziedzic M, Mlak R, Batura-Gabryel H, Sagan D, Krawczyk P, Milanowski J, Malecka-Massalska T. The diagnostic role of plasma circulating precursors of miRNA-944 and miRNA-3662 for non-small cell lung cancer detection. Pathol Res Pract. 2017;213(11):1384\u20137.","journal-title":"Pathol Res Pract"},{"key":"5620_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12885-016-2470-3","volume":"16","author":"A Flores-Perez","year":"2016","unstructured":"Flores-Perez A, Marchat LA, Rodriguez-Cuevas S, Bautista VP, Fuentes-Mera L, Romero-Zamora D, Maciel-Dominguez A, de la Cruz OH, Fonseca-Sanchez M, Ruiz-Garcia E, et al. Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells. BMC Cancer. 2016;16:379.","journal-title":"BMC Cancer"},{"issue":"7","key":"5620_CR19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/2211-5463.12215","volume":"7","author":"T Pan","year":"2017","unstructured":"Pan T, Chen W, Yuan X, Shen J, Qin C, Wang L. miR-944 inhibits metastasis of gastric cancer by preventing the epithelial-mesenchymal transition via MACC1\/met\/AKT signaling. FEBS Open Bio. 2017;7(7):905\u201314.","journal-title":"FEBS Open Bio"},{"issue":"6","key":"5620_CR20","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.3892\/or.2017.5611","volume":"37","author":"L Wen","year":"2017","unstructured":"Wen L, Li Y, Jiang Z, Zhang Y, Yang B, Han F. miR-944 inhibits cell migration and invasion by targeting MACC1 in colorectal cancer. Oncol Rep. 2017;37(6):3415\u201322.","journal-title":"Oncol Rep"},{"issue":"1","key":"5620_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0165-4608(01)00510-6","volume":"131","author":"YC Yang","year":"2001","unstructured":"Yang YC, Shyong WY, Chang MS, Chen YJ, Lin CH, Huang ZD, Wang HMT, Chen ML. Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma. Cancer Genet Cytogenet. 2001;131(1):48\u201353.","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"5620_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JMM Walboomers","year":"1999","unstructured":"Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139.","journal-title":"J Pathol"},{"issue":"9","key":"5620_CR23","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/jnci\/92.9.690","volume":"92","author":"H zur Hausen","year":"2000","unstructured":"zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92(9):690\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"5620_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.virol.2008.11.017","volume":"384","author":"HL Howie","year":"2009","unstructured":"Howie HL, Katzenellenbogen RA, Galloway DA. Papillomavirus E6 proteins. Virology. 2009;384(2):324\u201334.","journal-title":"Virology"},{"issue":"2","key":"5620_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.virol.2008.10.006","volume":"384","author":"ME McLaughlin-Drubin","year":"2009","unstructured":"McLaughlin-Drubin ME, Munger K. The human papillomavirus E7 oncoprotein. Virology. 2009;384(2):335\u201344.","journal-title":"Virology"},{"issue":"11","key":"5620_CR26","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1073\/pnas.1401430111","volume":"111","author":"XH Wang","year":"2014","unstructured":"Wang XH, Wang HK, Li Y, Hafner M, Banerjee NS, Tang S, Briskin D, Meyers C, Chow LT, Xie X, et al. microRNAs are biomarkers of oncogenic human papillomavirus infections. P Natl Acad Sci USA. 2014;111(11):4262\u20137.","journal-title":"P Natl Acad Sci USA"},{"issue":"9","key":"5620_CR27","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/bjc.2012.109","volume":"106","author":"CB Lajer","year":"2012","unstructured":"Lajer CB, Garnaes E, Friis-Hansen L, Norrild B, Therkildsen MH, Glud M, Rossing M, Lajer H, Svane D, Skotte L, et al. The role of miRNAs in human papillomavirus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer. Br J Cancer. 2012;106(9):1526\u201334.","journal-title":"Br J Cancer"},{"issue":"7645","key":"5620_CR28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature21386","volume":"543","author":"Cancer Genome Atlas Research","year":"2017","unstructured":"Cancer Genome Atlas Research. N, Albert Einstein College of M, analytical biological S, Barretos Cancer H, Baylor College of M, Beckman Research Institute of City of H, Buck Institute for research on a, Canada's Michael smith genome sciences C, Harvard medical S, Helen FGCC et al: Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378\u201384.","journal-title":"Nature"},{"issue":"8","key":"5620_CR29","doi-asserted-by":"publisher","first-page":"13375","DOI":"10.18632\/oncotarget.14533","volume":"8","author":"CE Banister","year":"2017","unstructured":"Banister CE, Liu C, Pirisi L, Creek KE, Buckhaults PJ. Identification and characterization of HPV-independent cervical cancers. Oncotarget. 2017;8(8):13375\u201386.","journal-title":"Oncotarget"},{"issue":"7","key":"5620_CR30","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.molonc.2014.03.019","volume":"8","author":"J Ma","year":"2014","unstructured":"Ma J, Mannoor K, Gao L, Tan A, Guarnera MA, Zhan M, Shetty A, Stass SA, Xing L, Jiang F. Characterization of microRNA transcriptome in lung cancer by next-generation deep sequencing. Mol Oncol. 2014;8(7):1208\u201319.","journal-title":"Mol Oncol"},{"issue":"8","key":"5620_CR31","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1007\/s13277-015-3252-2","volume":"36","author":"C Wang","year":"2015","unstructured":"Wang C, Jiang T. MicroRNA-335 represents an independent prognostic marker in cervical cancer. Tumour Biol. 2015;36(8):5825\u201330.","journal-title":"Tumour Biol"},{"issue":"1","key":"5620_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/qjmed\/hcw101","volume":"110","author":"S Azizmohammadi","year":"2017","unstructured":"Azizmohammadi S, Safari A, Azizmohammadi S, Kaghazian M, Sadrkhanlo M, Yahaghi E, Farshgar R, Seifoleslami M. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection. QJM. 2017;110(1):11\u20135.","journal-title":"QJM"},{"issue":"6","key":"5620_CR33","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.3802\/jgo.2017.28.e75","volume":"28","author":"W Jiang","year":"2017","unstructured":"Jiang W, Pan JJ, Deng YH, Liang MR, Yao LH. Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer. J Gynecol Oncol. 2017;28(6):e75.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"5620_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ijc.28010","volume":"133","author":"LL Christensen","year":"2013","unstructured":"Christensen LL, Tobiasen H, Holm A, Schepeler T, Ostenfeld MS, Thorsen K, Rasmussen MH, Birkenkamp-Demtroeder K, Sieber OM, Gibbs P, et al. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer. Int J Cancer. 2013;133(1):67\u201378.","journal-title":"Int J Cancer"},{"key":"5620_CR35","first-page":"40","volume":"5","author":"I Nordentoft","year":"2012","unstructured":"Nordentoft I, Birkenkamp-Demtroder K, Agerbaek M, Theodorescu D, Ostenfeld MS, Hartmann A, Borre M, Orntoft TF, Dyrskjot L. miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer. BMC Med Genet. 2012;5:40.","journal-title":"BMC Med Genet"},{"issue":"53","key":"5620_CR36","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1038\/sj.onc.1202953","volume":"18","author":"M Thomas","year":"1999","unstructured":"Thomas M, Pim D, Banks L. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene. 1999;18(53):7690\u2013700.","journal-title":"Oncogene"},{"key":"5620_CR37","doi-asserted-by":"crossref","unstructured":"Caldeira S, Dong W, Tommasino M. Analysis of E7\/Rb associations. Methods Mol Med. 2005;119:363\u201379.","DOI":"10.1385\/1-59259-982-6:363"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5620-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5620-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5620-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T23:10:07Z","timestamp":1588633807000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5620-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,6]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5620"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5620-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,6]]},"assertion":[{"value":"29 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Ethics Committee of Yonsei University Wonju Severance Christian Hospital (approval no. CR315052), and all subjects provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"419"}}